1. Home
  2. UTHR vs DKS Comparison

UTHR vs DKS Comparison

Compare UTHR & DKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UTHR
  • DKS
  • Stock Information
  • Founded
  • UTHR 1996
  • DKS 1948
  • Country
  • UTHR United States
  • DKS United States
  • Employees
  • UTHR N/A
  • DKS N/A
  • Industry
  • UTHR Biotechnology: Pharmaceutical Preparations
  • DKS Other Specialty Stores
  • Sector
  • UTHR Health Care
  • DKS Consumer Discretionary
  • Exchange
  • UTHR Nasdaq
  • DKS Nasdaq
  • Market Cap
  • UTHR 20.7B
  • DKS 20.6B
  • IPO Year
  • UTHR 1999
  • DKS N/A
  • Fundamental
  • Price
  • UTHR $437.62
  • DKS $217.28
  • Analyst Decision
  • UTHR Buy
  • DKS Buy
  • Analyst Count
  • UTHR 16
  • DKS 20
  • Target Price
  • UTHR $472.94
  • DKS $248.53
  • AVG Volume (30 Days)
  • UTHR 629.5K
  • DKS 962.3K
  • Earning Date
  • UTHR 10-29-2025
  • DKS 11-25-2025
  • Dividend Yield
  • UTHR N/A
  • DKS 2.23%
  • EPS Growth
  • UTHR 16.08
  • DKS 5.15
  • EPS
  • UTHR 26.38
  • DKS 14.31
  • Revenue
  • UTHR $3,128,400,000.00
  • DKS $13,772,123,000.00
  • Revenue This Year
  • UTHR $13.82
  • DKS $13.98
  • Revenue Next Year
  • UTHR $5.71
  • DKS $7.84
  • P/E Ratio
  • UTHR $16.63
  • DKS $15.21
  • Revenue Growth
  • UTHR 13.50
  • DKS 2.70
  • 52 Week Low
  • UTHR $266.98
  • DKS $166.37
  • 52 Week High
  • UTHR $479.50
  • DKS $254.60
  • Technical
  • Relative Strength Index (RSI)
  • UTHR 54.98
  • DKS 41.17
  • Support Level
  • UTHR $409.15
  • DKS $215.44
  • Resistance Level
  • UTHR $479.50
  • DKS $234.87
  • Average True Range (ATR)
  • UTHR 13.84
  • DKS 6.46
  • MACD
  • UTHR -0.64
  • DKS -1.28
  • Stochastic Oscillator
  • UTHR 40.46
  • DKS 8.59

About UTHR United Therapeutics Corporation

United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. In addition, it is developing a pipeline of projects that includes new indications and delivery devices for existing products and new products to treat PAH and other conditions.

About DKS Dick's Sporting Goods Inc

Dick's Sporting Goods is a retailer that offers sports and outdoor apparel, footwear, and equipment online and in physical stores. The company's legacy business includes more than 700 stores under its own name, more than 100 Golf Galaxy golf specialty stores, and about 50 outlet stores. In September 2025, Dick's acquired multinational retailer Foot Locker. With this move, Dick's added more than 2,300 stores under the Foot Locker, Kids Foot Locker, Champs Sports, atmos, and WSS nameplates in North America, the Asia-Pacific, and EMEA—Europe, the Middle East, and Africa. Based in the Pittsburgh area, Dick's was founded in 1948 by the father of current executive chair and controlling shareholder Edward Stack.

Share on Social Networks: